Use of apo b secretion/mtp inhibitors and anti-obesity agents

Details Use of apo b secretion/mtp inhibitors and anti-obesity agents Use of apo b secretion/mtp inhibitors and anti-obesity agents

A - Human Necessities

61

K

A61K 31/472 (2006.01) A61K 31/4468 (2006.01) A61K 31/454 (2006.01) A61K 45/06 (2006.01) A61P 3/06 (2006.01)

Patent

CA 2324801

The invention provides methods and pharmaceutical compositions useful in treating obesity in an animal, preferably a mammal including a human subject, a companion animal, or livestock, using an apo B secretion/MTP inhibitor and an anti-obesity agent. The invention further relates to a kit comprising an amount of an apolipoprotein B secretion/microsomal triglyceride transfer protein inhibitor and a pharmaceutically acceptable carrier, vehicle or diluent in a first unit dosage form; an amount of an anti-obesity agent and a pharmaceutically acceptable carrier, vehicle or diluent in a second unit dosage form; and a container.

Affiliated with

Also associated with

Rating

Use of apo b secretion/mtp inhibitors and anti-obesity agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of apo b secretion/mtp inhibitors and anti-obesity agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of apo b secretion/mtp inhibitors and anti-obesity agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1419596